15-33780327-C-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_001036.6(RYR3):​c.9254C>G​(p.Pro3085Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00399 in 1,613,820 control chromosomes in the GnomAD database, including 21 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0030 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0041 ( 18 hom. )

Consequence

RYR3
NM_001036.6 missense

Scores

2
6
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 6.11

Publications

6 publications found
Variant links:
Genes affected
RYR3 (HGNC:10485): (ryanodine receptor 3) The protein encoded by this gene is a ryanodine receptor, which functions to release calcium from intracellular storage for use in many cellular processes. For example, the encoded protein is involved in skeletal muscle contraction by releasing calcium from the sarcoplasmic reticulum followed by depolarization of T-tubules. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
RYR3 Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
  • congenital myopathy
    Inheritance: AR Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010045499).
BP6
Variant 15-33780327-C-G is Benign according to our data. Variant chr15-33780327-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 461984.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RYR3NM_001036.6 linkc.9254C>G p.Pro3085Arg missense_variant Exon 65 of 104 ENST00000634891.2 NP_001027.3 Q15413-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RYR3ENST00000634891.2 linkc.9254C>G p.Pro3085Arg missense_variant Exon 65 of 104 1 NM_001036.6 ENSP00000489262.1 Q15413-1

Frequencies

GnomAD3 genomes
AF:
0.00298
AC:
453
AN:
152198
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00433
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00547
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00281
AC:
699
AN:
248350
AF XY:
0.00284
show subpopulations
Gnomad AFR exome
AF:
0.000712
Gnomad AMR exome
AF:
0.000581
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00367
Gnomad NFE exome
AF:
0.00461
Gnomad OTH exome
AF:
0.00265
GnomAD4 exome
AF:
0.00409
AC:
5979
AN:
1461504
Hom.:
18
Cov.:
31
AF XY:
0.00398
AC XY:
2893
AN XY:
727028
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33478
American (AMR)
AF:
0.000559
AC:
25
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.000191
AC:
5
AN:
26132
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39684
South Asian (SAS)
AF:
0.00173
AC:
149
AN:
86204
European-Finnish (FIN)
AF:
0.00425
AC:
227
AN:
53400
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.00477
AC:
5303
AN:
1111764
Other (OTH)
AF:
0.00412
AC:
249
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.470
Heterozygous variant carriers
0
275
550
824
1099
1374
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00297
AC:
453
AN:
152316
Hom.:
3
Cov.:
32
AF XY:
0.00255
AC XY:
190
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000577
AC:
24
AN:
41576
American (AMR)
AF:
0.000523
AC:
8
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4822
European-Finnish (FIN)
AF:
0.00433
AC:
46
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00547
AC:
372
AN:
68018
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
23
45
68
90
113
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00434
Hom.:
2
Bravo
AF:
0.00258
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00597
AC:
23
ESP6500AA
AF:
0.000514
AC:
2
ESP6500EA
AF:
0.00350
AC:
29
ExAC
AF:
0.00277
AC:
335
EpiCase
AF:
0.00425
EpiControl
AF:
0.00427

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jan 12, 2022
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RYR3 NM_001036.4 exon 65 p.Pro3085Arg (c.9254C>G): This variant has not been reported in the literature but is present in 0.5% (372/68026) of European alleles including 3 homozygotes in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/15-33780327-C-G?dataset=gnomad_r3). This variant is present in ClinVar classified as a benign variant (Variation ID:461984). Evolutionary conservation suggests that this variant may not impact the protein; computational predictive tools for this variant are unclear. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore, the clinical significance of this variant is uncertain. -

Dec 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RYR3: BP4, BS2 -

Epileptic encephalopathy Benign:1
Oct 15, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RYR3-related disorder Benign:1
Jan 04, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.65
D;.;.;.;.
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.96
D;D;D;D;D
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.010
T;T;T;T;T
MetaSVM
Benign
-0.63
T
MutationAssessor
Uncertain
2.2
M;M;.;.;.
PhyloP100
6.1
PrimateAI
Benign
0.48
T
PROVEAN
Pathogenic
-5.2
.;D;.;.;.
REVEL
Benign
0.27
Sift
Benign
0.36
.;T;.;.;.
Polyphen
0.29
B;B;.;.;.
Vest4
0.46
MVP
0.29
MPC
0.24
ClinPred
0.035
T
GERP RS
5.5
Varity_R
0.25
gMVP
0.30
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61996335; hg19: chr15-34072528; API